|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:acquiredBy
|
gptkb:Pharmacia
gptkb:Warner-Lambert
gptkb:Seagen
gptkb:Wyeth
gptkb:Array_BioPharma
gptkb:Hospira
|
|
gptkbp:businessModel
|
public
|
|
gptkbp:CEO
|
gptkb:Albert_Bourla
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:COVID-19VaccinePartner
|
gptkb:BioNTech
|
|
gptkbp:developedVaccineFor
|
gptkb:COVID-19
|
|
gptkbp:divested
|
gptkb:Consumer_Healthcare_(joint_venture_with_GSK)
Upjohn (merged with Mylan to form Viatris)
Animal Health (spun off as Zoetis)
Nutrition (sold to Nestlé)
|
|
gptkbp:foundedBy
|
gptkb:Charles_F._Erhart
gptkb:Charles_Pfizer
|
|
gptkbp:foundedYear
|
1849
|
|
gptkbp:headquartersLocation
|
gptkb:New_York_City
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Pfizer Inc.
|
|
gptkbp:industry
|
gptkb:biotechnology
pharmaceuticals
|
|
gptkbp:listedOn
|
gptkb:Dow_Jones_Industrial_Average
gptkb:S&P_500
|
|
gptkbp:logo
|
Pfizer_logo.svg
|
|
gptkbp:memberOf
|
gptkb:Pharmaceutical_Research_and_Manufacturers_of_America
|
|
gptkbp:netIncome
|
$2.1 billion (2023)
|
|
gptkbp:notable_executive
|
gptkb:Frank_D'Amelio
gptkb:Mikael_Dolsten
gptkb:Ian_Read
gptkb:Jeffrey_Kindler
|
|
gptkbp:notableEvent
|
COVID-19 vaccine emergency use authorization (2020)
acquisition of Hospira (2015)
acquisition of Seagen (2023)
acquisition of Wyeth (2009)
merger with Warner-Lambert (2000)
|
|
gptkbp:notableProduct
|
gptkb:Comirnaty
gptkb:Lipitor
gptkb:Lyrica
gptkb:Paxlovid
gptkb:Prevnar
gptkb:Viagra
gptkb:Zoloft
|
|
gptkbp:numberOfEmployees
|
approximately 83,000 (2023)
|
|
gptkbp:officialWebsite
|
https://www.pfizer.com/
|
|
gptkbp:revenue
|
$58.5 billion (2023)
|
|
gptkbp:servesArea
|
worldwide
|
|
gptkbp:stockExchange
|
gptkb:NYSE
|
|
gptkbp:stockSymbol
|
gptkb:PFE
|
|
gptkbp:subsidiary
|
gptkb:Greenstone
gptkb:Upjohn
|
|
gptkbp:bfsParent
|
gptkb:Charles_Pfizer_Jr.
gptkb:PFE
|
|
gptkbp:bfsLayer
|
5
|